Despite significant advancements with recombinant AAV2 or AAV8 vectors for liver directed gene therapy in humans, it is well-recognized that host and vector-related immune challenges need to be overcome for long-term gene transfer. To overcome these limitations, alternate AAV serotypes (1-10) are be...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!